Products for Research Use Only
RegisterLogin

Gimsilumab

CAT: 0804-HY-P99642-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99642-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA) [1][2].
CAS Number
1648796-29-5
Product Name Alternative
MORAb-022
UNSPSC
12352203
Target
C-Fms; SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection; Protein Tyrosine Kinase/RTK
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gimsilumab.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Gimsilumab]
Molecular Weight
(145.765 kDa)
References & Citations
[1]Criner GJ, et al. Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 2022 Jun 1;205 (11) :1290-1299. |[2]Crotti C, et al. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date. Drug Des Devel Ther. 2017 Jan 13;11:211-223.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831437-01Gimsilumab
GTR18337742-01Gimsilumab Antibody
MBS1563369-01Research Grade Gimsilumab
E55B0289Gimsilumab (Reference antibody)
KBI1362KRIBIOLISA™ Gimsilumab ELISA
591895Gimsilumab (CSF2, GM-CSF)
ICH5574-10mgGimsilumab Biosimilar - Research Grade
GTR18780562-01(Gimsilumab) Biosimilar Reference Antibody
GTR18697970-01Gimsilumab Human Monoclonal Antibody
048422CSF2/GM-CSF (gimsilumab) discontinued

Popular Products